MARKETS / NASDAQ / SBRA
NASDAQ · REAL ESTATE INVESTMENT TRUSTS · LARGE CAP

Sabra Health Care Reit, Inc. SBRA

15 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$356.9M
▲ 25.4% vs FY2024
EPS · FY25
$0.64
Dividend / sh · FY25
$1.20
Payout · FY25
186%
ROE · FY25
5.6%
Net margin · FY25
43.6%
Dividend coverage
0.5×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 356.9M
Revenue, FY2025 · full 15-year series below
Revenue Net income
0.10.20.30.40.40.2201120142017202020232025
0.10.20.30.40.40.22016201920222025

44 cents of every revenue dollar became profit this year.

Per share
USD 0.64
Diluted EPS, FY2025
EPS Dividend
0.81.62.41.200.64201120142017202020232025
0.81.62.41.200.642016201920222025

Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.

Profitability
5.6%
Return on equity, FY2025
ROE
2.557.5105.6%201120142017202020232025
2.557.5105.6%2016201920222025
Operating margin
Net margin43.6%
Return on assets2.9%

Each USD of equity produced 6 cents of profit this year.

Returned to shareholders
USD 289.5M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 289.5M
Net buybacks
Share of profit186.0%
Consecutive raises

USD 289.5M in dividends — 186% of the year's profit, so the payout drew on cash built up earlier.

Growth
+18.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+24.1%
+18.0%
+4.1%
Net income
+2.4%
+7.0%
EPS, diluted
−0.9%
Dividend / share
+0.0%
−2.3%
Returned to shareholders
+1.5%
+0.8%
+10.2%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.25B
Shares outstanding, FY2025
0.040.25201120142017202020232025
0.070.252016201920222025
Change, 5 years+19.5%
Change, 10 years

The share count grew 20% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 5.5B
total assets, end of FY2025
Total assetsUSD 5.5B
EquityUSD 2.8B
CashUSD 71.5M
Gross debtUSD 2.5B
Net debtUSD 2.5B

Net debt stands at 87% of equity.

History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Revenue $B
0.4
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.0
0.3
0.2
0.2
0.1
0.1
0.1
Operating income $B
·
·
·
·
·
0.2
0.1
0.3
0.2
0.1
0.1
·
·
·
0.0
EBITDA $B
·
·
·
·
·
0.3
0.3
0.5
0.3
0.1
0.1
·
·
·
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.2
0.1
0.0
−0.1
−0.1
0.1
0.1
0.3
0.2
0.1
0.1
0.0
0.0
0.0
0.0
EPS, diluted $
0.64
0.54
0.06
−0.34
−0.52
0.67
0.37
1.51
1.40
0.92
1.11
0.78
0.68
0.52
0.43
Dividend / sh $
1.20
1.20
1.20
1.20
1.20
1.35
1.80
1.80
1.73
1.67
1.60
1.51
1.36
1.32
0.96
Payout %
186
221
2017
−357
−232
201
486
117
115
170
138
174
172
251
246
ROE %
5.6
4.6
0.5
−2.4
−3.3
4.0
2.0
8.4
7.1
6.8
8.0
6.7
8.8
6.2
3.9
Shares out B
0.25
0.24
0.23
0.23
0.23
0.21
0.21
0.18
0.18
0.07
0.07
0.06
0.04
0.04
0.04

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
30 of 30
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed